Life Settlement Assets plc (LSAA) ORD USD0.01 A
Sell:$1.52
Buy:$1.77
0
Change:
No change
No change
Market closed |
Prices as at close on 18 April 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:$1.52
Buy:$1.77
Change:
No change
No change
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 18 April 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Sell:$1.52
Buy:$1.77
Change:
No change
No change
Market closed |
Prices as at close on 18 April 2024
Prices delayed by at least 15 minutes
|
Switch to live prices
|
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
To generate long-term returns s for investors by investing in the life settlement market.
| Security | Weight |
|---|---|
| Hiv Portfolio | 47.63% |
| Elderly Life Insurance (Non Hiv) Portfolio | 20.49% |
| Premiums Paid In Advance | 4.16% |
Top 10 sectors currently unavailable.
Top 10 countries currently unavailable.
Fee Structure
Management fee payable monthly is 1.5% of the NAV. Performance fee shall be equal to 20% of the sum of the distributions made to the holders, in excess of the Performance Hurdle. The Contract is terminable on 6 months notice.
Dividend Policy
The Company has no stated dividend target. The Company aims to distribute a substantial portion of its funds derived from its operations in respect of a Share Class as dividends to Shareholders of that share class. There can be no assurance that the Company will be able to achieve this aim. The Company will only pay dividends on the Ords to the extent that it has sufficient financial resources available for that purpose.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Michael BainesChairman, Christopher Casey, Behcet Turkmen
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.